Posts tagged HIV cure news

A 3D image of HIV antibodies and cells in the bloodstream.

New HIV Antibodies Created to Fight Off the Virus

0
A 3D image of HIV antibodies and cells in the bloodstream.

New HIV antibodies could lead to a cure.

Scientists have made a huge step towards fighting off the HIV virus. Researchers at The Scripps Research Institute (TSRI) were able to attach HIV antibodies to immune cells in their most recent study. These new cells could potentially be the cure that millions infected with the life-threatening disease need. Find out what the scientists at TSRI had to say about their research and how these new cells eliminate the virus from the body.

How Do the HIV Antibodies Work?

Typically, antibodies float in the bloodstream alongside the cells in the body. However, the HIV antibodies developed by the researchers work a little differently. The scientists were able to tether the antibodies to immune cells. This technique created a new population of resistant cells that can replace cells affected by the disease.

This close connection with the immune cells is what Jia Xie, a senior staff scientist at TSRI and first author of the study, called the “neighbor effect.” Essentially, the antibodies hang on to a cell’s surface, acting as a barrier between HIV and the cell’s receptor. This action prevents HIV from infecting the cells and spreading throughout the body.

“This protection would be long term,” said Jia Xie. “You don’t need to have so many molecules on one cell to be effective,” he said.

How Was the Test Preformed?

Xie and his researchers first tested the tethering system against the rhinovirus, which is otherwise known as the common cold. The researchers were able to apply a new gene to cultured human cells. This gene is the one responsible for the creation of the antibodies that attached to immune cells.

The antibodies protected the cell receptors from the virus, halting infection. When adding rhinovirus to the testing, many of the unprotected cells died off. However, the newly created antibodies were able to thrive as the number of cell populations recovered to almost normal levels.

The next step after this success was to test the antibodies against HIV. The goal was for the HIV antibodies to protect the CD4 cells, which are usually the target of HIV. In the end, an HIV-resistant population of cells grew, while the old cells died. This is exactly the type of success that the team at TSRI was looking for.

What This Means for the Future

Antiretroviral drugs are the primary defense against HIV. The problem with this type of medication is that they have to be taken daily. Sometimes, HIV-positive individuals still suffer from higher rates of diseases when taking the drugs.

When discussing the TSRI’s research and new techniques, Joseph Alvarnas, M.D., director of Value-Based Analytics at the City of Hope, states “HIV is treatable but not curable–this remains a disease that causes a lot of suffering. That makes the case for why these technologies are so important.”

The research still has a long way to go. Scientists are testing to find out what other parts of the cell the new antibodies can protect. Hopefully, this can lead to a potential cure.

A doctor is drawing blood from a patients arm, prepping for treatment for HIV.

Beware of Dangerous ‘Shock and Kill’ Treatment for HIV

0
A doctor is drawing blood from a patients arm, prepping for treatment for HIV.

In the search for a cure, some treatment for HIV proves deadly.

Finding effective treatment for HIV is a long-standing battle. Scientists are fighting against the disease every day. The search for answers may lead to drastic measures. However, at what point do the risk outweigh the cure? That’s the question posed by researchers at the Johns Hopkins University of Medicine when it comes to the ‘shock and kill’ treatment.

What is the ‘Shock and Kill’ Treatment for HIV?

The shock-and-kill treatment reveals HIV hidden within the cells. This is the problem that many scientists run into – HIV hides. When it is dormant, the virus does not trigger the immune system to fight back. It’s also the reason that antiretroviral therapies are only capable of keeping the disease at bay.

The proposed shock-and-kill treatment essentially wakes HIV from its dormant state to make it vulnerable to the immune system and antiretroviral drugs. However, testing this method has led scientists to believe the supposed ‘cure’ could have disastrous results.

The treatment was tested on the simian immunodeficiency virus (SIV), a disease that is found in primates and is very much similar to HIV. One of the test subjects displayed encephalitis symptoms and brain inflammation. The symptoms only worsened and the primate had to be put down humanely.

This treatment spells trouble if the disease is hiding within the brain. Activation in this area only makes a patient’s condition worse, especially when scientists do not know where the disease is hiding to begin with. Researchers advise caution.

“The potential for the brain to harbor significant HIV reservoirs that could pose a danger if activated hasn’t received much attention in the HIV eradication field,” says Janice Clements, Ph.D., professor of molecular and comparative pathobiology at the Johns Hopkins University School of Medicine. “Our study sounds a major cautionary note about the potential for unintended consequences of the shock-and-kill treatment strategy.”

Several antibodies are attacking a foreign protein.

Using Antibodies in an Attempt to Find a Vaccine

0
Several antibodies are attacking a foreign protein.

Scientists hope to develop a cure for HIV by researching successful antibodies.

The human immune system is a fascinating network capable of performing incredible feats. Even when HIV is involved, nearly one-third of individuals are capable of producing effective antibodies against the virus. Researchers have turned their attention to the antibodies produced during infection in order to facilitate the creation of an effective vaccine.

While some immune systems are adept at producing antibodies that act to neutralize a broad range of HIV strains, the process could, and often does, take up to a year before it is in full swing. Ideally, a vaccine should help a patient immediately combat the viral intrusion. This is one important goal for those developing vaccines. Efforts to speed up the process and make the antibodies available for everyone has prompted scientific study.

Certain effective antibodies were selected and closely examined. Of those, some had loop-like structures which, when they encountered the virus, were able to cling tightly and neutralize it. With the aid of computer modeling, modifications were made to the existing antibodies so as to maximize their efficiency. It is expected that such modifying will help increase the response time of the immune system, even if a person has never previously had contact with HIV.

Amino Acids Within Antibodies

Another aspect that was carefully reviewed was how the amino acids were sequenced in the antibodies that had proven most effective. Of the antibodies with a loop structure, certain ones had specific amino acid sequences that researchers tested and noted. A successful vaccine needs to provide adequate protection against more than just one or two strains of the tenacious virus. Those that were able to neutralize more strains were again plugged into the computer and modified. The re-engineering was to increase the capabilities of these powerhouse molecules.

Tests were also conducted to confirm that the alterations being made would, in fact, prove effective. The spectrum that the vaccine is designed to cover is wide, and when factoring in the potency of the design, researchers feel confident that if implemented, most people who are vaccinated would produce an effective response.

Promising Results in HIV Trials

0

The scientific community has relentlessly been in pursuit of an effective vaccine against HIV infection. With a competent vaccine in the arsenal, researchers could buy time to find a cure. Not only that, prevention is one way to curb its spread and help contain the disease. New information on the virus is discovered on a regular basis. Putting the facts together to formulate a line of defense has taken patience and time. However, it seems there is a reason to hope that a new vaccine won’t stay a fantasy forever.

Vaccine Proves Effective in HIV Trials

A research group in China completed pre-clinical HIV trials for a vaccine meant to prevent infection that women get from men. Not only did the vaccine prove effective, it performed better than expected. In an effort to confirm these findings, a group in the U.S. repeated the HIV trials, and added some rigorous testing. The results were the same, much to the delight of the scientists.

The vaccine in question was designed to protect women from seminal being transmitted to mucous membranes. In the studies, vaginal tissues were exposed to high viral loads – up to 70,000 times more than what is found in human semen. The vaccine was successful in warding off infection. Repeat exposure was tested as well. These also were fought off with the help of the vaccine. When they increased the viral amounts to 100,000 times the normal range, the immune system was overloaded and succumbed to the viral infection.

Experts are looking into how that might affect the vaccine — and ways to make it more potent. Another positive point that pleased the researchers was that certain environmental factors were inherently different between the two studies, yet the results yielded the same outcomes. The group is confident that with this confirming study, clinical HIV trials can proceed with little worry.

When and if that does happen, it could open doors for further vaccine testing and marketing. One other goal that has been in line with producing vaccines is designing them to be ingested instead of injected. The aim is to reach people in developing countries where resources may be limited.

HIV Protein Image May Be the Next Step Toward a Vaccine

0

A boost to the war against HIV would be to produce an effective vaccine. Over the decades, research has continued to provide promising strategies for disengaging the viral attack on a host. However, much of this research comes to a halt when it comes time to implement the information. The reason for this standstill has to do with the actual physical makeup of the virus. Creating an antibody has proven not to be out of the scientists’ reach, but getting that antibody to stick to the virus has.

Next Step Toward a Vaccine

In order to neutralize the invading virus, the antibody must attach itself. HIV is so well protected that this has proven futile. In an effort to see vulnerabilities in the viral membrane, researchers have tried to get a closer look at some of the external parts that are attached to the membrane. For years, this also seemed out of reach. Many of the proteins that are attached to the virus are delicate and unstable. Attempts at capturing the image resulted in breaking the structure because of its fragile nature. This losing streak, though, just came to an end. Finally, a high-resolution image of a key protein on the outside of the viral wall has been taken. Now, scientists will be able to study the segment and see what approach to take so that antibodies can adequately attach themselves.

This protein is not only a vulnerable part of the virus, but it also happens to be very consistent among various strands of HIV. In other words, it does not mutate as much as other structures. This means that when a vaccine is produced with antibodies that can attach to this protein, it should be able to cover a vast array of HIV infections. There will be no need for multiple vaccines. Also discovered is that while this would be an ideal site to neutralize the virus, there is a shield around it. This sugar-like substance conceals the area and will make contact difficult for antibodies. Taking a closer look at these molecules will help researchers break down the defense so that the immune system can do its job.

Go to Top